Loans Against Private Company Stock: Comprehensive Guide to Unlocking Liquidity

Many high-net-worth individuals hold significant wealth in private company shares, but these assets are often illiquid and not easily accessible for everyday expenses. Loans against private company shares allow you to borrow money using your ownership in a private business as collateral, providing cash while you retain your shares and any future upside.

These loans enable you to unlock liquidity from assets that are otherwise difficult to convert to cash. You avoid selling your shares and the associated tax consequences, maintaining full ownership and the potential to benefit from future company growth or a public offering. The loan provides immediate capital for purposes such as purchasing property, launching new ventures, or covering large expenses.

Private share loans differ from traditional stock loans. Since private companies are not publicly traded, lenders conduct thorough due diligence, assessing company financials, your ownership stake, and the likelihood of liquidity events such as a sale or IPO. If you meet the lender’s criteria, funding can often be arranged within a few weeks.

Key Takeaways

• Borrow between 20% and 40% of your private shares’ value while maintaining ownership and deferring taxes on a sale
• Lenders evaluate your company’s financial health, your equity stake, and potential liquidity events to determine loan terms
• These loans carry risks if share values decline, but provide fast access to capital without waiting for a company exit

How Stock-Backed Lending Works

Stock-backed lending uses your company shares as collateral to secure a loan without selling them. The process varies for private versus public shares, and lenders structure these transactions to protect both parties while you retain ownership.

Key Features of Unlisted Stock Loans

Unlisted stock loans provide liquidity while your shares remain in your name. You maintain voting rights and entitlement to dividends. The lender receives a security interest in your shares rather than outright ownership.

Loan terms typically range from one to five years. You may choose to pay interest only during the term or both principal and interest. Interest rates generally fall between 6% and 12%, determined by your company’s financial profile and the loan’s structure.

Main features include:

• Non-recourse structure – The lender’s claim is limited to the pledged shares in the event of default
• No prepayment penalties – You can repay the loan early if a liquidity event occurs
• Flexible draw schedules – Some lenders allow incremental access to funds as needed

Unlike margin loans on public shares, you are not subject to margin calls due to short-term market volatility, since private share values do not fluctuate daily.

Types of Securities-Backed Lending

Securities-backed lending takes several forms. A term loan provides a lump sum with a fixed repayment date, suitable for specific purchases or investments.

A securities-based line of credit allows you to draw funds up to a set limit as needed, with interest accruing only on the amount used. This is ideal for variable cash needs or maintaining standby liquidity.

Stock loans use equity shares as collateral, while other securities-backed loans may accept bonds, mutual funds, or ETFs. For private company shareholders, the focus is on unlisted stock loan products tailored for non-public shares.

Some lenders offer payment-in-kind structures, where interest accrues and is paid at maturity. Others require periodic cash payments throughout the loan term.

The Role of Securities as Collateral

Your shares serve as the lender’s security. You sign a pledge agreement granting the lender rights to sell the shares if you default. Shares are typically held in escrow or a custodial account during the loan.

Collateral valuation is based on recent funding rounds, third-party appraisals, or comparable company analyses, as there is no public market price. This assessment determines your borrowing capacity.

Transfer restrictions in shareholder agreements impact collateral eligibility. Provisions such as rights of first refusal or transfer blocks require legal solutions to secure the lender’s interest. Restricted stock units or shares with vesting schedules may not qualify.

Your collateral remains segregated from the lender’s assets. If the lender encounters financial difficulties, your shares are still protected and returned upon repayment.

Eligibility, Lender Criteria, and Structuring

Not all shareholders or shares qualify for loans against private company stock. Lenders set strict eligibility criteria based on the borrower’s profile, share type, and risk mitigation through legal documentation.

Borrower Requirements and Share Types

Lenders usually require a significant equity stake in a company with strong fundamentals and institutional backing. Shares must be transferable or pledgeable, making restricted stock loans more complex. Lenders often prefer companies backed by private equity or venture capital, which supports valuation and governance standards.

Common equity is typically easier to borrow against than preferred shares, which may have added rights or restrictions. The size of your stake is important; lenders generally seek holdings worth several million pounds or more to justify the underwriting process for private credit market transactions.

A credible exit strategy is also necessary. Without a clear path to liquidity—such as a sale, IPO, or refinancing—lenders may decline to offer a facility or may propose less favorable terms.

How Lenders Assess Risk and Value

Without a public market price, lenders rely on comprehensive company analysis to assess value and risk. This includes reviewing financial statements, revenue trends, profitability, and cash flow.

The loan-to-value (LTV) ratio is central to structuring. Most lenders offer an LTV between 15% and 45%, depending on company maturity and investor base. Private equity-backed companies may support higher ratios than early-stage ventures.

Lenders assess concentration risk, as the loan is secured by a single company’s shares. This lack of diversification drives a focus on downside risk scenarios in private debt market underwriting.

Credit approval depends on the lender’s ability to quantify recovery in adverse situations. The less liquid the shares, the more conservative the loan terms.

Legal and Pledge Agreement Considerations

A pledge agreement establishes the lender’s security interest in your shares, detailing rights, obligations, and default procedures. It must address share transfer restrictions, which are common in private companies.

Shareholder agreements may require consents or rights of first refusal that could delay or prevent a lender from taking control of the shares. Lenders scrutinize these clauses during due diligence. Non-transferable shares may require additional collateral or guarantees.

The pledge agreement also specifies enforcement procedures. In illiquid markets, enforcement may be slow or uncertain, making legal clarity essential for private credit transactions.

Loan Terms, Ratios, and Repayment Structures

Loan-to-value ratios typically range from 20% to 65% of share value. Repayment structures include fixed-term loans and revolving credit lines, each with distinct interest and maturity terms.

Loan-to-Value and Lending Value

The LTV ratio determines how much cash you can access against your private shares. Most lenders offer between 30% and 50% of assessed share value, compared to 70% to 85% for public stocks.

Lending value is influenced by your company’s financial health, including revenue, profit margins, and recent funding rounds.

Ownership percentage also affects the LTV. Majority shareholders or founders may qualify for higher ratios than minority stakeholders. Holdings below 10% of the company may result in lower lending values.

Share class impacts borrowing capacity:

• Preferred shares may support higher LTVs than common stock
• Voting shares often receive more favorable terms
• Restricted stock can reduce the maximum loan amount

Companies with impending liquidity events, such as a planned IPO or acquisition within 12 to 24 months, may qualify for higher LTVs of 50% to 65%, compared to the standard 30% to 40%.

Interest Rates and Repayment Periods

Interest rates on private stock loans typically range from 6% to 12% per year, based on risk assessment, company strength, and market conditions.

Two primary repayment structures exist. Cash-pay loans require periodic interest payments (monthly or quarterly), with principal repaid at maturity.

Payment-in-kind loans allow interest to accrue and compound, with all amounts due at maturity. This preserves cash flow during the loan term but increases the total repayment.

Repayment periods generally span one to ten years. Shorter terms of one to three years are suitable for anticipated quick liquidity events, while longer terms provide flexibility but result in higher total interest costs.

Unlike margin loans for public stocks, private stock loans have fixed repayment periods, protecting you from sudden repayment demands if share values decline.

Fixed-Term Loans vs. Lines of Credit

Fixed-term loans provide a lump sum at closing, with a set maturity date and predetermined repayment schedule. This option is ideal for specific capital needs, such as property purchases or significant investments.

A line of credit or SBLOC offers a maximum borrowing amount, with funds drawn as needed. You pay interest only on amounts drawn, and can borrow, repay, and borrow again during the availability period.

Key differences:

• Fixed-term loans accrue interest on the full amount from the outset
• Lines of credit charge interest only on drawn amounts
• Fixed-term loans provide predictable payments and timelines
• Lines of credit offer flexibility for ongoing or variable needs

Lenders actively monitor lines of credit, adjusting available amounts based on company performance or valuation changes. Fixed-term loans generally maintain stable terms unless you default.

Most private stock loans are non-recourse arrangements, meaning the lender’s claim is limited to the pledged shares if you fail to repay.

Benefits and Strategic Uses

Loans against private company stock enable shareholders to access capital while retaining ownership and deferring immediate tax liabilities. These facilities address challenges of private market illiquidity and allow for portfolio diversification without asset sales.

Unlocking Liquidity While Staying Invested

Private company shareholders often have significant “paper wealth” but limited access to cash. A loan against private company shares provides liquidity by converting equity into usable capital without requiring a stock sale.

By borrowing against your shares, you maintain your position in the company, preserving dividend rights, voting power, and potential for future appreciation.

Traditional loans may require different collateral or extensive paperwork. Securities-backed lending leverages your existing shares as collateral, often resulting in faster approval—sometimes within days.

This solution is well-suited for those needing cash for specific purposes while expecting future growth in company value. Common uses include real estate purchases, new business ventures, or covering unexpected expenses.

Tax Planning and Capital Gains Strategies

Selling private company stock creates a taxable event. You must pay capital gains taxes on any profit from the sale. These taxes can reach 20% at the federal level, plus state taxes in many locations.

When you borrow against your shares instead of selling them, you defer capital gains taxes. The loan proceeds are not considered taxable income. You receive cash without triggering immediate tax liability.

This strategy becomes especially valuable if you hold highly appreciated stock. The larger your unrealized gain, the more you defer by not selling. You can postpone taxes while still accessing the value of your holdings.

Diversification and Wealth Management

Concentrated positions in private company stock create risk. If too much of your wealth sits in one company, your financial health depends on that business.

Loans against your private stock provide capital to diversify your holdings. You can use the borrowed funds to invest in other assets like real estate, public stocks, or bonds. This spreads your risk across multiple investments while you stay invested in your original company shares.

Family offices and high-net-worth individuals use this approach in estate planning. You can structure loans to provide liquidity for estate taxes or to transfer wealth to heirs while maintaining control of the underlying shares.

Risks and Challenges in Unlisted Stock Lending

Borrowing against private company shares carries unique risks tied to valuation uncertainty, share restrictions, and market volatility. These challenges can affect both your ownership stake and your ability to maintain the loan.

Market Fluctuations and Margin Calls

Private company valuations can change quickly based on financial performance, funding rounds, or market conditions. Unlike publicly traded stocks with daily pricing, private shares lack transparent market values. This makes it harder to predict when a lender might reassess your collateral.

When your share value drops below a certain threshold, lenders can issue a margin call. You'll need to either add more collateral, pay down part of the loan, or deposit cash to meet the required loan-to-value ratio. If you can't meet these demands within the specified timeframe, the lender may move toward forced liquidation.

Common triggers for margin calls include:

• Poor quarterly earnings or missed revenue targets
• Failed funding rounds or down-round valuations
• Industry downturns affecting sector confidence
• Changes in company leadership or strategy

Forced Liquidation and Ownership Impacts

Forced liquidation happens when you can't satisfy a margin call and the lender exercises their right to sell your shares. This can result in losing both your equity stake and any future upside if the company grows or goes public.

The process becomes more complex with private shares because there's no public market for quick sales. Lenders may sell to other investors, back to the company, or through secondary markets at potentially unfavorable prices. You could also lose voting rights and decision-making power in the company.

Your loan agreement should clearly state how forced sales work and what protections you have. Some lenders allow grace periods or alternative arrangements before selling your shares.

Managing Restrictive Share Agreements

Many private companies have shareholder agreements that limit how you can use shares as collateral. These restrictions protect the company and other shareholders but can complicate or block lending entirely.

Key restrictions to review:

• Right of first refusal: The company or other shareholders must approve any pledge or transfer
• Lock-up periods: Shares can't be moved or pledged during specific timeframes
• Pre-emption rights: Other shareholders get priority if shares need to be sold
• Board approval: Company directors must consent to using shares as collateral

You'll need written consent from relevant parties before pledging shares. Your lawyer should review all shareholder agreements, articles of association, and company bylaws to identify potential barriers.

Frequently Asked Questions

Private share lending involves complex valuation methods, strict documentation requirements, and specific risk factors that differ significantly from traditional lending. Lenders assess everything from company financials to transfer restrictions when structuring these loans.

How do lenders value privately held shares when determining loan eligibility and terms?

Lenders use recent funding round valuations as a primary benchmark when assessing your private shares. If your company raised capital within the past 12 to 18 months, that valuation serves as a starting point for determining collateral value.

Third-party appraisals become necessary when recent funding rounds are unavailable. Lenders commission independent valuation experts who analyze your company's financial statements, revenue growth, profitability, and comparable company metrics.

Internal financial performance carries substantial weight in the valuation process. Your lender will review audited accounts, EBITDA figures, revenue projections, and cash flow statements to assess the underlying business strength.

The liquidity outlook affects valuation directly. Companies approaching an IPO, acquisition, or trade sale receive higher valuations because lenders see a clear path to monetization. Your shares in a company with no exit plan face more conservative valuations.

What collateral and documentation are typically required to borrow against unlisted company shares?

You must pledge your shares as primary collateral through a legal charge or security agreement. The lender registers this charge against the shares, giving them rights to the equity if you default on the loan.

Company articles of association and shareholder agreements require thorough review. Lenders need to verify that no clauses prevent you from pledging your shares or that pre-emption rights won't interfere with their security position.

Share certificates and proof of ownership form part of the core documentation package. You'll need to provide official certificates showing the number of shares you own and any transfer documents if shares changed hands previously.

Recent company accounts and financial statements are mandatory for due diligence. Most lenders require at least three years of audited financials, management accounts for the current year, and forward-looking projections.

Valuation reports from qualified professionals support your loan application. These reports establish the fair market value of your shares and help lenders determine appropriate loan amounts.

Personal financial information remains necessary even though shares serve as collateral. You'll submit bank statements, tax returns, and details of other assets and liabilities to complete the underwriting process.

What loan-to-value ratios are common for loans secured by private company stock, and what affects them?

Standard LTV ratios range from 20% to 40% of your share value for most private company loans. This conservative approach reflects the illiquid nature of unlisted shares and valuation uncertainty.

Strong company fundamentals can push LTVs to 65% or higher. Companies with solid revenue growth, positive cash flow, and clear profit margins qualify for more aggressive lending terms because they present lower risk.

Your shareholding percentage influences the LTV you receive. Majority shareholders or those with significant voting control access better terms than minority shareholders because their position carries more influence and value.

Upcoming liquidity events substantially improve LTV ratios. If your company plans an IPO within 12 to 24 months or is in acquisition talks, lenders offer higher LTVs based on expected share monetization.

Transfer restrictions limit your available LTV. Shares with complex transfer requirements or strong pre-emption rights receive lower LTVs because they're harder for lenders to liquidate if needed.

The company's sector and market position affect lending terms. Technology companies with high growth potential often receive better LTVs than traditional businesses with slower growth trajectories.

How do interest rates and fees for stock-secured loans compare to portfolio-backed lending against public equities?

Private share loans typically carry interest rates between 6% and 9% per annum. These rates run higher than public equity loans because of increased valuation complexity and reduced liquidity.

Public equity lending starts around 3% to 5% for the same loan amounts. The difference reflects the ease of valuing and selling listed shares compared to private holdings.

Arrangement fees for private share loans range from 1% to 3% of the loan value. You pay these upfront costs to cover legal work, due diligence, and structuring complexity that private deals require.

Valuation costs add to your total expense when borrowing against private shares. You'll typically pay between $5,000 and $25,000 for professional valuations depending on company size and complexity.

Legal fees run higher for private share transactions than public equity deals. Expect to pay $10,000 to $50,000 in legal costs to structure the security properly and review all company documentation.

Annual monitoring fees may apply if your loan extends beyond 12 months. Lenders charge these fees to cover ongoing company performance reviews and valuation updates.

What are the key risks and drawbacks of pledging private shares as collateral, including margin calls or forced sale scenarios?

Share value decreases can trigger margin calls requiring additional collateral. If your company's valuation drops due to poor performance or market conditions, you must either provide more security or repay part of the loan.

Forced liquidation becomes possible if you cannot meet margin call requirements. The lender can exercise their security and sell your shares, though this process is more complex with private shares than listed securities.

Limited buyer markets for private shares complicate forced sales. Your lender may struggle to find purchasers quickly, potentially leading to sales at significant discounts to fair value.

Company performance risks directly affect your collateral value. Unlike diversified portfolios of public stocks, your loan depends on a single company's success or failure.

Personal liability remains even after pledging shares as security. Most lenders require personal guarantees, meaning they can pursue your other assets if share sales don't cover the outstanding debt.

Lock-up periods can create timing mismatches. If your company goes public, you may face restrictions on selling shares while loan repayment deadlines approach.

How do transfer restrictions, shareholder agreements, and company buyback rights impact the ability to use private shares as collateral?

Pre-emption rights require other shareholders to approve share transfers first. Many companies give existing shareholders the right to buy shares before they transfer to third parties, including lenders who enforce security.

Right of first refusal clauses can prevent lenders from taking direct ownership. When these clauses exist, the company or other shareholders can match any offer price before shares transfer, limiting lender security.

Drag-along and tag-along provisions affect how lenders can realize value. These clauses determine whether lenders can participate in or block company sales, impacting their ability to monetize pledged shares.

Board approval requirements add another layer of complexity. Some company articles require board consent before shareholders pledge shares, giving the company veto power over such financing.

Lock-up agreements restrict the ability to pledge shares temporarily.